
Nectar Lifesciences Announces 31st AGM Details
Nectar Lifesciences Ltd has announced the details for its 31st Annual General Meeting (AGM), scheduled for September 18, 2026, at 11:00 AM IST. The meeting will be conducted via Video Conferencing/Other Audio-Visual Means (VC/OAVM). Key agenda items include the adoption of standalone and consolidated financial statements for the financial year ended March 31, 2026, along with the Directors' and Auditors' reports. Additionally, the AGM will address the re-appointment of Mr. Sanjiv Goyal as a director retiring by rotation and the re-appointment of Dr. Kuldip Kumar Bhasin as an Independent Director for a second term. The company has also included a disclaimer regarding forward-looking statements within its Annual Report.
Key Highlights
- 31st AGM scheduled for September 18, 2026, via VC/OAVM.
- Agenda includes adoption of FY26 financial statements and reports.
- Re-appointment of directors Mr. Sanjiv Goyal and Dr. Kuldip Kumar Bhasin.
- Annual Report 2025-2026 available, containing forward-looking statements.
Price Impact
More from NECLIFE